CPSC Recall in 2025: Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Updated on March 25, 2026.

See the recall details below. You can also see similar information for other consumer product recalls in 2025.

Data Source: CPSC.

Recall Number: 26-157

Date: December 18, 2025

Product Name: Mamisan Pain Relieving Topical Ointment

Recall Description:

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Hazard Description:

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the https://www.cpsc.gov/Business--Manufacturing/Business-Education/Busines… lang="EN">Poison Prevention Packaging Act. The ointment’s packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

Consumer Action:

Remedy Type:

Repair

Units: About 50,330

Incidents:

None reported

Sold At:

Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.

Manufactured In:

United States